ArticleDiabetic medicine : a journal of the British Diabetic Association2026
Persistence of proinsulin-only secretion in people with long-duration diabetes and minimal residual insulin secretion.
Article in Diabetic medicine : a journal of the British Diabetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
BACKGROUND AND
aimsIn all forms of diabetes, beta cell failure is associated with disproportionate proinsulin secretion, a marker of endoplasmic reticulum stress. Histopathological studies have suggested that defective expression of prohormone convertases may lead to proinsulin becoming the predominant secretory product. We analysed meal-stimulated proinsulin secretion in people with minimal residual C-peptide secretion. MATERIALS AND
methodsWe studied a cohort of 320 individuals, among whom 55 exhibited poorly stimulated C-peptide levels (peak <0.3 nmol/L) during a 2-h mixed-meal tolerance test (MMTT; carbohydrates (60 g), lipids (5.5 g), proteins (10 g)). Serum C-peptide (Diasorin, LOQ 0.01 nmol/L) and proinsulin (ELISA, Mercodia, LOQ 0.5 pmol/L) were measured at baseline and at 60 and 120 min. Responses were assessed using peak values and peak-to-basal ratios. Results are expressed as median [interquartile range].
resultsAmong these 55 individuals, most had type 1 diabetes (n = 44); other aetiologies included type 2 diabetes (n = 1) and other forms (n = 10). Diabetes duration was 18 [8-25] years, HbA1c was 61 mmol/mol (7.7%), and all subjects were insulin-treated (0.6 [0.47-0.79] U/kg/day). Peak C-peptide was 0.03 [0.001-0.12] nmol/L, peak proinsulin was 0.8 [0.5-1.75] pmol/L. Among participants with non-stimulated C-peptide (n = 14) following MMTT, 5 showed stimulated proinsulin secretion.
conclusionThe presence of stimulated proinsulin secretion in long-standing diabetes with minimal residual C-peptide secretion suggests the persistence of dysfunctional yet meal-responsive beta cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.